In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells (Q39775722)

14 September 2017

title

In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells (English)

1 reference

14 September 2017

0 references

0 references

1 reference

Fedor Kryukov

1

1 reference

14 September 2017

Darina Ocadlíková

2

1 reference

14 September 2017

Lucie Kovárová

3

1 reference

14 September 2017

Ivana Buresová

4

1 reference

14 September 2017

Roman Hájek

5

1 reference

14 September 2017

Jaroslav Michálek

6

1 reference

14 September 2017

publication date

1 December 2009

1 reference

Journal of Immunotoxicology

14 September 2017

published in

1 reference

14 September 2017

volume

6

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

243-248

1 reference

Dendritic cells and the control of immunity

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Structure and function of telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Class II MHC peptide loading by the professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Activation of telomerase in a human tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Multiple myeloma: evolving genetic events and host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Immunodeficiency and immunotherapy in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

21 January 2018

Telomerase and cancer

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Dendritic cell vaccines for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15476910903236134

10.3109/15476910903236134

21 January 2018

Identifiers

DOI

1 reference

release_q2mg3eoffrfcdal5m5wx7qint4

14 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q2mg3eoffrfcdal5m5wx7qint4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference